Donor oocyte cycle characteristics and outcomes: factors potentially linked with successful endings.

Objective The use of donor oocytes in assisted reproduction has seen a significant rise worldwide in the last two decades. Postponement of motherhood and premature ovarian insufficiency are the main reasons for the increase in the number of in vitro fertilization cycles with donor oocytes. The present study aims to characterize donor oocyte cycles to analyze factors that may have an effect on live births and clinical pregnancy outcomes. Methods Data were obtained from a single Assisted Reproduction Center in southern Brazil. Recipient demographics (n=148 patients) and cycle characteristics (n=213 cycles; 50 patients did more than one IVF attempt) were analyzed. Statistical analysis was performed using chi-squared and t-test as appropriate. Results On average, recipients that reached gestation were significantly younger than the ones that did not. We also observed a significant positive effect of constant dose estrogen therapy on pregnancies. Conclusions Patient age and response to estradiol therapy are important factors in the attainment of the best possible outcomes in cycles with donor oocytes.

[1]  L. Aghajanova,et al.  Assessing the impact of semen quality on embryo development in an egg donation model , 2020, F&S reports.

[2]  M. Hill,et al.  Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomes. , 2020, Human reproduction.

[3]  R. Vassena,et al.  Efficiency and efficacy of vitrification in 35 654 sibling oocytes from donation cycles. , 2020, Human reproduction.

[4]  Z. Rosenwaks,et al.  Preimplantation genetic testing for aneuploidy (PGT-A) in donor oocyte single blastocyst transfer cycles: is there benefit? , 2019, Fertility and Sterility.

[5]  Z. Rosenwaks,et al.  Oocyte donation: insights gleaned and future challenges. , 2018, Fertility and sterility.

[6]  Z. Nagy,et al.  Impact of male partner characteristics and semen parameters on in vitro fertilization and obstetric outcomes in a frozen oocyte donor model. , 2018, Fertility and sterility.

[7]  D. Albertini,et al.  Impact of preimplantation genetic screening on donor oocyte‐recipient cycles in the United States , 2017, American journal of obstetrics and gynecology.

[8]  Christine Wyns,et al.  Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE , 2017, Human reproduction.

[9]  M. Olovsson,et al.  Which factors are most predictive for live birth after in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments? Analysis of 100 prospectively recorded variables in 8,400 IVF/ICSI single-embryo transfers. , 2017, Fertility and sterility.

[10]  R. Vassena,et al.  Use of donor sperm in addition to oocyte donation after repeated implantation failure in normozoospermic patients does not improve live birth rates. , 2016, Human Reproduction.

[11]  R. Vassena,et al.  Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer. , 2016, Human reproduction.

[12]  B. Whitcomb,et al.  Semen parameters do not have a clinically significant effect on ICSI cycle outcomes: an analysis using 2,861 shared oocyte donor recipient cycles to control for egg factors , 2015 .

[13]  J. Goldfarb,et al.  Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology. , 2013, Fertility and sterility.

[14]  A. Shelling.  Premature ovarian failure. , 2010, Reproduction.

[15]  A. P. Walsh,et al.  IVF for premature ovarian failure: first reported births using oocytes donated from a twin sister , 2010, Reproductive biology and endocrinology : RB&E.

[16]  B. Vollenhoven,et al.  In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? , 2009, Journal of Assisted Reproduction and Genetics.

[17]  E. Girsh,et al.  Male age influences oocyte-donor program results , 2008, Journal of Assisted Reproduction and Genetics.

[18]  C. Simón,et al.  Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. , 2005, The Journal of clinical endocrinology and metabolism.

[19]  D. Grainger,et al.  Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996–19981 1Reprints are not available. , 2002 .

[20]  D. Grainger,et al.  Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996-1998. , 2002, Fertility and sterility.

[21]  D. Gardner,et al.  Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. , 2000, Fertility and sterility.

[22]  F. Rojas,et al.  OOCYTE DONATION AND GAMETE INTRAFALLOPIAN TRANSFER AS TREATMENT FOR PREMATURE OVARIAN FAILURE , 1987, The Lancet.

[23]  V. M. Lopes,et al.  Doação de óvulos: alternativa eficaz quando a mulher não puder utilizar os próprios gametas , 2015 .

[24]  Z. Rosenwaks,et al.  Oocyte donation: insights into implantation. , 1999, Fertility and sterility.